Editing UGT1A1

'''UGT1A1''' is an enzyme that in humans is encoded by the UGT1A1 gene. It is a member of the [[UDP-glucuronosyltransferase]] (UGT) family, which plays a significant role in the [[glucuronidation]] process. 

== Function ==

The UGT1A1 enzyme is primarily found in the [[liver]] and the [[gastrointestinal tract]]. It is responsible for the glucuronidation of bilirubin, a waste product of red blood cell breakdown. This process makes bilirubin water-soluble, allowing it to be excreted in the bile and urine. 

== Clinical significance ==

Mutations in the UGT1A1 gene can lead to several diseases. The most common of these is [[Gilbert's syndrome]], a mild and usually asymptomatic condition characterized by intermittent jaundice. More severe mutations can cause [[Crigler-Najjar syndrome]], a rare and potentially lethal disease that results in severe jaundice and can lead to brain damage.

UGT1A1 is also involved in the metabolism of certain drugs, including [[irinotecan]], a chemotherapy medication. Variations in the UGT1A1 gene can affect how individuals respond to this drug, with certain variants associated with a higher risk of toxicity.

== Genetic testing ==

[[Genetic testing]] can identify mutations in the UGT1A1 gene. This can be useful for diagnosing Gilbert's syndrome and Crigler-Najjar syndrome, as well as for predicting an individual's response to drugs metabolized by UGT1A1.

== See also ==

* [[UDP-glucuronosyltransferase]]
* [[Glucuronidation]]
* [[Gilbert's syndrome]]
* [[Crigler-Najjar syndrome]]
* [[Irinotecan]]

[[Category:Enzymes]]
[[Category:Genes]]
[[Category:Genetic testing]]
[[Category:Genetic diseases]]
{{Enzymes}}
{{Genes}}
{{Genetic testing}}
{{Genetic diseases}}
{{medicine-stub}}

{{No image}}